We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cambridge Cognition Holdings Plc | LSE:COG | London | Ordinary Share | GB00B8DV9647 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 52.00 | 51.00 | 53.00 | 52.00 | 52.00 | 52.00 | 3,300 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 12.61M | -409k | -0.0117 | -44.44 | 18.12M |
TIDMCOG
RNS Number : 2008O
Cambridge Cognition Holdings PLC
08 June 2022
Cambridge Cognition Holdings Plc
(" Cambridge Cognition" or the "Company")
Result of AGM
Cambridge Cognition, which develops and markets digital solutions to assess brain health, held its Annual General Meeting ("AGM") earlier today at the registered office of the Company; Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU. Resolutions 1 to 6 put to the AGM were duly passed and resolution 7 was not passed.
Proxy votes were received in respect of approximately 34% of the Company's issued share capital and the proxy votes received in respect of each resolution were as follows:
Resolution For Against Withheld 1 - To approve the 2021 report and accounts 9,609,585 90.23% 1,040,000 9.77% 133 ----------- -------- ---------- ------- --------- 2 - To reappoint the auditors 10,643,921 99.95% 5,664 0.05% 133 ----------- -------- ---------- ------- --------- 3 - to authorise the directors to set the auditors remuneration 10,649,585 100.00% 0 0.00% 133 ----------- -------- ---------- ------- --------- 4 - to re-elect Steven Powell as a director 10,630,812 99.99% 547 0.01% 18,359 ----------- -------- ---------- ------- --------- 5 - to re-elect Matthew Stork as a director 10,631,159 99.99% 200 0.01% 18,359 ----------- -------- ---------- ------- --------- 6 - authority to allot shares 9,606,038 90.23% 1,040,200 9.77% 3,480 ----------- -------- ---------- ------- --------- 7 - disapplication of pre-emption rights 5,188,039 48.73% 5,458,199 51.27% 3,480 ----------- -------- ---------- ------- ---------
Enquiries
Cambridge Cognition Holdings plc www.cambridgecognition.com Matthew Stork, Chief Executive Officer Tel: 01223 810 700 Stephen Symonds, Chief Financial Officer Panmure Gordon (UK) Limited (NOMAD and Joint Broker) Tel: 020 7220 0500 Freddy Crossley / Emma Earl / Mark Rogers (Corporate Advisory) Rupert Dearden (Corporate Broking) Dowgate Capital Limited (Joint Broker) Tel: 020 3903 7715 David Poutney / James Serjeant (Corporate Broking) IFC Advisory Ltd (Financial PR and IR) Tel: 020 3934 6630 Tim Metcalfe / Graham Herring / Zach Cohen cog@investor-focus.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGBKFBDQBKDBAK
(END) Dow Jones Newswires
June 08, 2022 10:14 ET (14:14 GMT)
1 Year Cambridge Cognition Chart |
1 Month Cambridge Cognition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions